CORBF
Price
$2.98
Change
-$0.00 (-0.00%)
Updated
Sep 23, 6:59 PM EST
THMO
Price
$0.58
Change
+$0.06 (+11.54%)
Updated
May 17, 6:59 PM EST
Ad is loading...

CORBF vs THMO

Header iconCORBF vs THMO Comparison
Open Charts CORBF vs THMOBanner chart's image
Global Cord Blood
Price$2.98
Change-$0.00 (-0.00%)
Volume$4.53M
CapitalizationN/A
ThermoGenesis Holdings
Price$0.58
Change+$0.06 (+11.54%)
Volume$52.71K
CapitalizationN/A
View a ticker or compare two or three
CORBF vs THMO Comparison Chart

Loading...

THMODaily Signal changed days agoGain/Loss if shorted
 
Show more...
COMPARISON
Comparison
May 19, 2024
Stock price -- (CORBF: $1.23 vs. THMO: $0.59)
Brand notoriety: CORBF and THMO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CORBF: 3% vs. THMO: 269%
Market capitalization -- CORBF: $154M vs. THMO: $2.24M
CORBF [@Medical Specialties] is valued at $154M. THMO’s [@Medical Specialties] market capitalization is $2.24M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.49B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORBF’s FA Score shows that 0 FA rating(s) are green whileTHMO’s FA Score has 0 green FA rating(s).

  • CORBF’s FA Score: 0 green, 5 red.
  • THMO’s FA Score: 0 green, 5 red.
According to our system of comparison, CORBF is a better buy in the long-term than THMO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

THMO’s TA Score shows that 4 TA indicator(s) are bullish.

  • THMO’s TA Score: 4 bullish, 5 bearish.

Price Growth

CORBF (@Medical Specialties) experienced а -1.60% price change this week, while THMO (@Medical Specialties) price change was -12.40% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.34%. For the same industry, the average monthly price growth was +4.51%, and the average quarterly price growth was +16.96%.

Reported Earning Dates

CORBF is expected to report earnings on Feb 27, 2023.

THMO is expected to report earnings on Mar 27, 2023.

Industries' Descriptions

@Medical Specialties (+2.34% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for CORBF with price predictions.
OPEN
A.I.dvisor published
a Summary for THMO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CORBF($154M) has a higher market cap than THMO($2.24M). CORBF has higher P/E ratio than THMO: CORBF (1.99) vs THMO (1.86). CORBF YTD gains are higher at: 0.820 vs. THMO (-2.346).
CORBFTHMOCORBF / THMO
Capitalization154M2.24M6,866%
EBITDAN/A-5.08M-
Gain YTD0.820-2.346-35%
P/E Ratio1.991.86106%
RevenueN/A9.72M-
Total CashN/A4.02M-
Total DebtN/A8.34M-
FUNDAMENTALS RATINGS
CORBF vs THMO: Fundamental Ratings
CORBF
THMO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
67100
PRICE GROWTH RATING
1..100
6491
P/E GROWTH RATING
1..100
4399
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CORBF's Valuation (58) in the Medical Or Nursing Services industry is in the same range as THMO (66) in the null industry. This means that CORBF’s stock grew similarly to THMO’s over the last 12 months.

CORBF's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as THMO (100) in the null industry. This means that CORBF’s stock grew similarly to THMO’s over the last 12 months.

CORBF's SMR Rating (67) in the Medical Or Nursing Services industry is somewhat better than the same rating for THMO (100) in the null industry. This means that CORBF’s stock grew somewhat faster than THMO’s over the last 12 months.

CORBF's Price Growth Rating (64) in the Medical Or Nursing Services industry is in the same range as THMO (91) in the null industry. This means that CORBF’s stock grew similarly to THMO’s over the last 12 months.

CORBF's P/E Growth Rating (43) in the Medical Or Nursing Services industry is somewhat better than the same rating for THMO (99) in the null industry. This means that CORBF’s stock grew somewhat faster than THMO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
THMO
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
THMODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RELI0.310.02
+7.86%
Reliance Global Group
PSN76.51-0.04
-0.05%
Parsons Corp
CLDT9.02-0.04
-0.44%
Chatham Lodging Trust
AGIO34.34-0.66
-1.89%
Agios Pharmaceuticals
PFIE1.38-0.04
-2.82%
Profire Energy

CORBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORBF has been loosely correlated with SINT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CORBF jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORBF
1D Price
Change %
CORBF100%
-1.60%
SINT - CORBF
38%
Loosely correlated
-39.29%
APYX - CORBF
36%
Loosely correlated
+4.58%
MBOT - CORBF
33%
Loosely correlated
-2.83%
QTRX - CORBF
30%
Poorly correlated
-0.06%
BVS - CORBF
30%
Poorly correlated
-3.77%
More

THMO and

Correlation & Price change

A.I.dvisor tells us that THMO and CORBF have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that THMO and CORBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THMO
1D Price
Change %
THMO100%
+12.74%
CORBF - THMO
26%
Poorly correlated
-1.60%
HBIO - THMO
25%
Poorly correlated
-2.03%
APDN - THMO
25%
Poorly correlated
-8.73%
GENE - THMO
23%
Poorly correlated
-0.44%
BFLY - THMO
23%
Poorly correlated
+1.98%
More